These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22805801)

  • 21. Characterization of Escherichia coli isolates from healthy food handlers in hospital.
    Luo Y; Cui S; Li J; Yang J; Lin L; Hu C; Jin S; Ye L; Zhao Q; Ma Y
    Microb Drug Resist; 2011 Sep; 17(3):443-8. PubMed ID: 21612511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress.
    Xie X; Lv R; Yang C; Song Y; Yan Y; Cui Y; Yang R
    J Microbiol; 2019 Dec; 57(12):1056-1064. PubMed ID: 31555989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia.
    Saiful Anuar AS; Mohd Yusof MY; Tay ST
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1744-7. PubMed ID: 23852897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.
    Lautenbach E; Metlay JP; Mao X; Han X; Fishman NO; Bilker WB; Tolomeo P; Wheeler M; Nachamkin I
    Clin Infect Dis; 2010 Aug; 51(3):280-5. PubMed ID: 20597679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
    Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.
    Geisinger E; Vargas-Cuebas G; Mortman NJ; Syal S; Dai Y; Wainwright EL; Lazinski D; Wood S; Zhu Z; Anthony J; van Opijnen T; Isberg RR
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugal transfer of PMQR from uropathogenic E.coli under high ciprofloxacin selection pressure generates gyrA mutation.
    Basu S; Mukherjee M
    Microb Pathog; 2019 Jul; 132():26-29. PubMed ID: 30999022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the efficacy of an algae-based treatment to mitigate elicitation of antibiotic resistance.
    Grimes KL; Dunphy LJ; Loudermilk EM; Melara AJ; Kolling GL; Papin JA; Colosi LM
    Chemosphere; 2019 Dec; 237():124421. PubMed ID: 31382196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
    Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
    Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.
    Begum YA; Talukder KA; Azmi IJ; Shahnaij M; Sheikh A; Sharmin S; Svennerholm AM; Qadri F
    PLoS One; 2016; 11(7):e0157415. PubMed ID: 27428376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutations of gyrA gene and parC gene in fluoroquinolone-resistant Escherichia coli isolates from sporadic diarrheal cases].
    Ishiguro F; Toho M; Yamazaki M; Matsuyuki S; Moriya K; Tanaka D; Isobe J; Kyota Y; Muraoka M
    Kansenshogaku Zasshi; 2006 Sep; 80(5):507-12. PubMed ID: 17073264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
    Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
    Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals.
    Mooij MJ; Schouten I; Vos G; Van Belkum A; Vandenbroucke-Grauls CM; Savelkoul PH; Schultsz C
    Clin Microbiol Infect; 2005 Nov; 11(11):898-902. PubMed ID: 16216105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.